8.3 C
New York
Wednesday, July 15, 2020
ECS Fin-Transaction Processing & Automation

Broadridge: Financial Services Firms Accelerating Technology Transformation

Broadridge: Financial Services Firms Accelerating Technology Transformation Broadridge a $4 billion global Fintech leader a leading provider of investor communications and technology-driven solutions to...

Latest Posts

Mypinpad: World’s first to achieve PCI CPoC accreditation

Mypinpad: World’s first to achieve PCI CPoC accreditation Achieve Payment Card Industry SSC certification for its Android software-based Contactless Payments on Commercial off-the-shelf (CPoC)...

Railsbank: Partnering with The Fintech House in Portugal

Railsbank: Partnering with The Fintech House in Portugal Portugal Fintech created by a team guided by their enthusiasm for technology and finance It has...

Nium: Announced a partnership with Visa

Nium: Announced a partnership with Visa Nium a global financial technology platform redefining the way consumers and businesses send, spend and receive funds across...

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated Zelira Therapeutics has confirmed its phase one dose-escalation trial of ZTL-103 has successfully met clinical endpoints...

Adyen: 8 ways to make the most out of a £102bn opportunity

Adyen: 8 ways to make the most out of a £102bn opportunity

  • Discovered that British retailers failing to deliver a great shopping experience are missing out on big revenue
  • Retail in the UK evolving, driven by a competitive market and shoppers demanding the latest tech to enhance their experience
  • Seamless shopper journeys are a must, and retailers need to embrace unified commerce to keep up
  • Adyen’s research found that four out of five (79%) Brits would not return to make a purchase if they went into a store only to find their desired item was out-of-stock
  • The research paired with 451 Research’s Global Unified Commerce Forecast found that running out of stock in-store is the biggest contributor to lost revenue
  • The important thing is to make the payment experience as seamless as possible
    Queues in-store are the second biggest source of lost revenues

Latest Posts

Mypinpad: World’s first to achieve PCI CPoC accreditation

Mypinpad: World’s first to achieve PCI CPoC accreditation Achieve Payment Card Industry SSC certification for its Android software-based Contactless Payments on Commercial off-the-shelf (CPoC)...

Railsbank: Partnering with The Fintech House in Portugal

Railsbank: Partnering with The Fintech House in Portugal Portugal Fintech created by a team guided by their enthusiasm for technology and finance It has...

Nium: Announced a partnership with Visa

Nium: Announced a partnership with Visa Nium a global financial technology platform redefining the way consumers and businesses send, spend and receive funds across...

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated Zelira Therapeutics has confirmed its phase one dose-escalation trial of ZTL-103 has successfully met clinical endpoints...

Trending Stories

Mypinpad: World’s first to achieve PCI CPoC accreditation

Mypinpad: World’s first to achieve PCI CPoC accreditation Achieve Payment Card Industry SSC certification for its Android software-based Contactless Payments on Commercial off-the-shelf (CPoC)...

Railsbank: Partnering with The Fintech House in Portugal

Railsbank: Partnering with The Fintech House in Portugal Portugal Fintech created by a team guided by their enthusiasm for technology and finance It has...

Nium: Announced a partnership with Visa

Nium: Announced a partnership with Visa Nium a global financial technology platform redefining the way consumers and businesses send, spend and receive funds across...

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated

Zelira Therapeutics: Confirms ZTL-103 is safe and well-tolerated Zelira Therapeutics has confirmed its phase one dose-escalation trial of ZTL-103 has successfully met clinical endpoints...

Imugene: Receives ethics approval for PD1-Vaxx trial

Imugene: Receives ethics approval for PD1-Vaxx trial Biotech company Imugene has received Human Research Ethics Committee (HREC) approval to begin a phase one clinical...

Stay in touch

To be updated with all the latest news, offers and special announcements.

X
X
X
X